NervGen Pharma Corp. Common stock (NGEN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.96
Day's range
$4.16

NervGen Pharma Corp Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
EMPERY ASSET MANAGEMENT, LP 08/11/2026 4.00 M $8.24 M   100.00% 4.33%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 1.21 M $2.49 M   100.00% 1.31%
DAFNA CAPITAL MANAGEMENT LLC 08/14/2026 1.05 M $2.16 M   100.00% 1.14%
GHISALLO CAPITAL MANAGEMENT LLC 08/14/2026 1.00 M $2.06 M   100.00% 1.08%
ARMISTICE CAPITAL, LLC 08/14/2026 678.00 K $1.40 M   100.00% 0.73%
LMR PARTNERS LLP 08/14/2026 600.00 K $1.24 M   100.00% 0.65%
MARSHALL WACE, LLP 08/13/2026 435.96 K $898.08 K   117.59% 0.47%
UBS GROUP AG 08/13/2026 379.73 K $782.24 K   517.27% 0.41%
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 271.68 K $559.66 K   100.00% 0.29%
JANE STREET GROUP, LLC 08/14/2026 270.75 K $557.75 K   100.00% 0.29%
WOODLINE PARTNERS LP 08/14/2026 250.50 K $516.03 K   100.00% 0.27%
PFG INVESTMENTS, LLC 07/23/2026 217.50 K $448.05 K   8.21% 0.24%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 189.40 K $390.16 K   100.00% 0.20%
BANK OF AMERICA CORP /DE/ 08/14/2026 186.20 K $383.57 K   -7.20% 0.20%
ROYAL BANK OF CANADA 08/14/2026 176.08 K $363.00 K   2.39% 0.19%
QUADRATURE CAPITAL LTD 08/07/2026 134.52 K $277.11 K   100.00% 0.15%
BANK OF MONTREAL /CAN/ 08/12/2026 78.39 K $284.38 K   24.63% 0.08%
INTEGRATED WEALTH CONCEPTS LLC 09/09/2026 74.22 K $152.88 K   -14.51% 0.08%
CAPTRUST FINANCIAL ADVISORS 08/13/2026 64.42 K $132.71 K   3.30% 0.07%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 58.04 K $119.56 K   100.00% 0.06%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 51.09 K $105.25 K   27.76% 0.06%
HRT FINANCIAL LP 08/14/2026 43.86 K $90.00 K   105.27% 0.05%
AXQ CAPITAL, LP 08/06/2026 43.10 K $88.78 K   100.00% 0.05%
MILLENNIUM MANAGEMENT LLC 08/14/2026 39.74 K $81.86 K   100.00% 0.04%
GREAT VALLEY ADVISOR GROUP, INC. 08/10/2026 35.50 K $73.13 K   69.05% 0.04%
VIRTU FINANCIAL LLC 08/13/2026 34.59 K $71.00 K   100.00% 0.04%
COMMONWEALTH EQUITY SERVICES, LLC 07/29/2026 33.00 K $67.98 K   -1.05% 0.04%
MCKINLEY CARTER WEALTH SERVICES, INC. 07/28/2026 32.65 K $67.27 K   5.70% 0.04%
TRAYNOR CAPITAL MANAGEMENT, INC. 07/22/2026 31.50 K $64.89 K   23.53% 0.03%
CETERA INVESTMENT ADVISERS 08/12/2026 31.40 K $64.68 K   0.00% 0.03%
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC 07/16/2026 28.50 K $58.71 K   -22.97% 0.03%
CITADEL ADVISORS LLC 09/02/2026 27.80 K $57.27 K   100.00% 0.03%
LPL FINANCIAL LLC 08/07/2026 26.71 K $55.02 K   99.33% 0.03%
ALMANACK INVESTMENT PARTNERS, LLC. 07/30/2026 25.75 K $53.05 K   23.06% 0.03%
BUSEY WEALTH MANAGEMENT 08/13/2026 25.00 K $51.50 K   0.00% 0.03%
SPROTT INC. 07/28/2026 25.00 K $51.50 K   0.00% 0.03%
TD WATERHOUSE CANADA INC. 07/27/2026 23.80 K $49.81 K   0.00% 0.03%
LIBERTY WEALTH MANAGEMENT LLC 08/06/2026 22.00 K $82.94 K   0.00% 0.02%
WELLS FARGO & COMPANY/MN 08/14/2026 22.00 K $45.32 K   100.00% 0.02%
ENVESTNET ASSET MANAGEMENT INC 08/03/2026 20.00 K $41.20 K   0.00% 0.02%
SRS CAPITAL ADVISORS, INC. 08/10/2026 19.73 K $40.64 K   9.42% 0.02%
GOLDMAN SACHS GROUP INC 08/14/2026 19.62 K $40.42 K   100.00% 0.02%
MARINER, LLC 08/13/2026 17.88 K $36.82 K   0.00% 0.02%
MOORS & CABOT, INC. 08/10/2026 17.04 K $35.09 K   100.00% 0.02%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 07/15/2026 16.46 K $30.95 K   100.00% 0.02%
CREATIVE PLANNING 08/13/2026 15.58 K $32.09 K   20.39% 0.02%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 15.50 K $32.00 K   0.00% 0.02%
JPMORGAN CHASE & CO 08/12/2026 14.71 K $28.84 K   9.30% 0.02%
MORGAN STANLEY 08/13/2026 12.94 K $26.65 K   7.99% 0.01%
SCOTIA CAPITAL INC. 08/11/2026 12.74 K $26.34 K   -1.98% 0.01%

NervGen Pharma Corp institutional Ownership - FAQ's

During the previous two years, 65 institutional investors and hedge funds held shares of NervGen Pharma Corp. The most heavily invested institutionals were:

Empery Asset Management, LP: 4 M

Rock Springs Capital Management LP: 1.21 M

DAFNA Capital Management LLC: 1.05 M

Ghisallo Capital Management LLC: 1,000,000

ARMISTICE CAPITAL, LLC: 678,000

LMR Partners LLP: 600,000

12.97% of NervGen Pharma Corp stock is owned by institutional investors.

Institutional investors have bought a total of 11.99 M shares in the last 24 months. This purchase volume represents approximately $49.77 M in transactions.